Dechra Pharmaceuticals
LSE:DPH GB0009633180
Key Information
HQ:
United Kingdom
Market Cap:
$4.79bn
Primary Markets:
Europe & Russia, North America
Company Information
Company Summary
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. The company offers various companion animal veterinary products, as well as water-soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle. It markets its products through wholesaler and distributor networks, as well as through an in-house team of sales representatives, of which many are qualified veterinarians. In January 2024, the company was delisted from the London Stock Exchange and officially taken private.